Exonic polymorphism (rs315952, Ser133Ser) of interleukin 1 receptor antagonist (IL1RN) is related to overweigh/obese with hypertension
Seung-Ae Yang
J Exerc Rehabil. 2014;10(5):332-336. Published online 2014 Oct 31 DOI: https://doi.org/10.12965/jer.140155
Citations to this article as recorded by 
Identification of an IL-1 receptor mutation driving autoinflammation directs IL-1-targeted drug design
Yusha Wang, Jun Wang, Wenjie Zheng, Jiahui Zhang, Jinbo Wang, Taijie Jin, Panfeng Tao, Yibo Wang, Chenlu Liu, Jiqian Huang, Pui Y. Lee, Xiaomin Yu, Qing Zhou
Immunity.2023; 56(7): 1485. CrossRef
Emerging Role of the Inflammasome and Pyroptosis in Hypertension
Carmen De Miguel, Pablo Pelegrín, Alberto Baroja-Mazo, Santiago Cuevas
International Journal of Molecular Sciences.2021; 22(3): 1064. CrossRef
Arterial Hypertension and Interleukins: Potential Therapeutic Target or Future Diagnostic Marker?
Daniela Maria Tanase, Evelina Maria Gosav, Smaranda Radu, Anca Ouatu, Ciprian Rezus, Manuela Ciocoiu, Claudia Florida Costea, Mariana Floria
International Journal of Hypertension.2019; 2019: 1. CrossRef
The interleukin-1β-511 T>C (rs16944) gene polymorphism is associated with risk of developing silent myocardial ischemia in diabetic patients
Gilberto Vargas-Alarcón, Miguel Cruz-López, Adán Valladares, Edith Álvarez-León, Teresa Juárez-Cedillo, Óscar Pérez-Méndez, Jorge Escobedo de-la-Peña, Galileo Escobedo, Jose Manuel Fragoso
Immunology Letters.2015; 168(1): 7. CrossRef